Back when I was first diagnosed with cancer, I bought a small bottle of good scotch whisky. It took a few weeks to go through, by which time we'd figured out that things were worse than they first appeared. This week I bought some more, and a small bit of it (a dram, I guess) is my regular evening treat these days:
Cheers. Later on I might even get some better stuff, though the Glenlivet is rather guid, regardless.
Incidentally, Genentech, the company that makes Avastin—the trade name for bevacizumab, which is the anti-cancer drug treatment currently coursing through my system—is #3 on the Wired 40 list this year. The blurb mentions Avastin by name, actually. So I now interact daily with all of the top three companies in the list.